Trial Information

Official Title: An Open-label, Pilot Study Evaluating the Efficacy of Enteric-coated Eicosapentaenoic Acid (o3mega+Joy) in the Treatment of Social Phobia

Summary

The primary objective is to evaluate the efficacy of an enteric-coated, eicosapentaenoic acid-concentrated fish oil in the treatment of social phobia. A secondary objective is to determine if treatment outcome is related to plasma phospholipid essential fatty acid status, niacin skin flush and measures of lipid/protein peroxidation.

Phase: Phase 2

Sponsor: START Clinic for Mood and Anxiety Disorders

Overall Contacts:

Martin A Katzman, MD
416 598 9344
mkatzman@startclinic.ca